Investment analysts at StockNews.com began coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) in a report released on Friday. The brokerage set a “sell” rating on the basic materials company’s stock.
Arcadia Biosciences Stock Performance
Shares of RKDA opened at $5.00 on Friday. The company’s 50-day simple moving average is $4.70 and its 200-day simple moving average is $3.61. Arcadia Biosciences has a 1 year low of $1.85 and a 1 year high of $10.31. The stock has a market capitalization of $6.83 million, a PE ratio of -1.17 and a beta of 0.90.
Arcadia Biosciences Company Profile
Featured Articles
- Five stocks we like better than Arcadia Biosciences
- How to Buy Cheap Stocks Step by Step
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- How to Calculate Inflation Rate
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- ESG Stocks, What Investors Should Know
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.